Doctor On Demand will add lab testing services to its repertoire
Beginning this summer, Doctor On Demand, a San Francisco, California-based telemedicine startup, will offer laboratory testing services.
LabCorp reportedly planning $8B buyout of CRO
Burlington, North Carolina-based LabCorp is rumored to be negotiating an $8 billion acquisition of Pharmaceutical Product Development (PPD), a global contract research organization operating in over 50 countries.
presented by
The Top 6 Best Analytics Tools for Health Care Revenue in 2025
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
After $371M merger, what comes next for LabCorp and Sequenom?
The two companies are perched on a risky, competitive genetic testing market valued in 2015 at $3 billion.
These are the key players in the home health testing market
The report lists obvious choices like Quest Diagnostics, LabCorp and 23andMe - and deigns to include even Theranos, despite its recent spate of bad PR.
Ativa Medical takes big leap forward with $15M Series B
Additional investors means additional, significant progress for St. Paul, Minnesota-based diagnostics company Ativa Medical.
Duke and LabCorp turn mill town into a biobank using Facebook’s business model
Jaron Lanier is a computer scientist who thinks that Facebook should pay users for their data. After all it’s the content from individual users that has enabled the company to become a billion-dollar business ($1.81 billion in Q2 2014). Without users posting comments and pictures and links, what does Facebook have? Nothing. How do users […]
presented by
The Best Options for Diagnostic Imaging Covered by Medicare
Health care professionals can refer patients to the best options for diagnostic imaging covered by Medicare to give more people the medical assistance they need without extra financial stress.
LabCorp builds up specialty testing unit with $241M MEDTOX acquisition
LabCorp (NYSE:LH) is set to acquire toxicology testing company MEDTOX Scientific (NASDAQ:MTOX) for $241 million as the laboratory testing and diagnostics firm builds out its specialty testing offerings. The definitive merger agreement calls for LabCorp to acquire MEDTOX for $27 per share in cash. That represents a 37 percent premium over MEDTOX’s $19.70 closing price […]
Lupus flare diagnostic to be developed under LabCorp, XDx partnership
LabCorp (NYSE:LH) is partnering with molecular diagnostics firm XDx to develop a new diagnostic for lupus flares. Burlington, North Carolina-based LabCorp will work with XDx to develop a biomarker and commercialize a test for the flares — extended periods of activity for the autoimmune disease. Lupus causes the body’s immune system to attack its own […]
LabCorp strikes deal for Alzheimer’s disease diagnostic
LabCorp (NYSE:LH) has struck a deal to develop and commercialize a new Alzheimer’s disease diagnostic. The Burlington, North Carolina lab services and diagnostics company has licensed rights to an Alzheimer’s diagnostic technology from OPKO Health (NYSE:OPK). The deal gives LabCorp exclusive rights to the OPKO technology in North America and the United Arab Emirates. No […]
LabCorp completes $85M acquisition of Orchid Cellmark
LabCorp (NYSE:LH), after waiting eight months for regulators’ blessings, had a speedy wrap up of its $85 million acquisition of DNA testing company Orchid Cellmark. Laboratory testing and diagnostics firm LabCorp secured the greater than 90 percent of shares in Orchid that allowed the company to proceed with a short-form merger, meaning the deal could […]
Navigating The Right Steps For Your Healthcare Startup
This webinar will explore how a banking platform approach could be the resource for your company.
LabCorp completes ORCH offer, extends deadline for remaining shares
LabCorp (NYSE:LH) has secured enough shares for its $85 million acquisition of DNA testing company Orchid Cellmark (NASDAQ:ORCH) but the company still wants more shares. Burlington, North Carolina-based LabCorp is extending its offer for the shareholders who did not tender their shares. The shares tendered represent 86.5 percent of Princeton, New Jersey-based Orchid’s outstanding shares, […]
LabCorp gets FTC OK for $85M Orchid acquisition
LabCorp (NYSE:LH) finally has the regulatory go-ahead to complete its $85 million acquisition of DNA testing company Orchid Cellmark (NASDAQ:ORCH). The laboratory services and diagnostics firm said that it has reached an agreement with the U.S. Federal Trade Commission that calls for the company to sell off parts of Orchid’s U.S. government paternity business following […]
Senate probes LabCorp’s alleged Medicare, Medicaid fraud
LabCorp (NYSE:LH) is under a federal probe investigating whether the laboratory services firm and others defrauded Medicare and Medicaid. The Senate inquiry comes months after a $49.5 million settlement with the state of California over claims that LabCorp overcharged California’s Medicaid program and gave doctors kickbacks for patient referrals. In a November 8 letter to […]
Here’s how new Roche cancer drug Zelboraf benefits LabCorp
A new Roche (OTC:RHHBY) cancer drug expected to become a blockbuster could also end up being a boon for laboratory and diagnostics firm LabCorp (NYSE:LH). The Roche drug Zelboraf was approved in August by the Food and Drug Administration to treat melanoma patients whose advanced skin cancer cannot be removed by surgery. But Zelboraf works […]
LabCorp partners with DHMRI to develop clinical research tests
LabCorp (NYSE:LH) will work with the David H. Murdock Research Institute to develop new testing tools that could be used in clinical research worldwide. Under the partnership with the DHMRI announced Wednesday, LabCorp’s clinical trials division, Esoterix, will provide the institute’s clients with access to test development services. New assays discovered and developed at DHMRI […]